PharmaShots

JUNE 23, 2023

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

FDA 40

FDA 40

PharmaShots

JUNE 16, 2023

Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B

FDA 40

FDA Labelling 40

The Checkup by Singlecare

NOVEMBER 2, 2023

Research in people with Type 2 diabetes has shown that GLP-1 receptor agonists may lower the chances of having a heart attack, stroke, or dying from cardiovascular (heart and blood vessel) problems. The high price tag is a barrier for many people. As such, these drugs may not be covered by patients’ insurance.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

The Checkup by Singlecare

SEPTEMBER 7, 2023

mg to 5 mg injected once weekly Mounjaro coupons Ozempic (semaglutide) Treatment of Type 2 diabetes mellitus as an adjunct to diet and exercise, Reduction of cardiovascular mortality 0.25 There are several options in the class, and while none are considered cheap, some are cheaper than Mounjaro without insurance.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

The Checkup by Singlecare

MARCH 21, 2023

Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. NSAID use is associated with an increased risk of cardiovascular events , including the development of high blood pressure. RELATED: Belbuca side effects 2.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

The Checkup by Singlecare

MAY 8, 2023

Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. NSAID use is associated with an increased risk of cardiovascular events’ , including the development of high blood pressure. fibromyalgia ).

Controlled Substances 52

Controlled Substances Dosage Labelling FDA 52

pharmaphorum

FEBRUARY 26, 2021

Cordis was founded in Miami in 1959 and develops and produces medical equipment to treat patients who suffer from cardiovascular disease. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. CEO Alex Gorsky, who was appointed in 2012.

Vaccines 124

Vaccines Labelling Communication 124